A. Dowlati

机构：University Hospitals of Cleveland, University Hospitals Seidman Cancer Center, Case Western Reserve University

发表论文 4 篇 · 总被引 40 次 · h-index 2

代表论文

• 441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC (2016 · Annals of Oncology · 被引 37)
• P3.18.80 A Phase 3 Study of Sacituzumab Govitecan in Patients With Previously Treated Extensive Stage Small Cell Lung Cancer (2025 · Journal of Thoracic Oncology · 被引 2)
• 161O RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) (2023 · Journal of Thoracic Oncology · 被引 1)
• P1.04.04 Effect of Social Determinants of Health on Lung Cancer Screening Uptake in the U.S (2025 · Journal of Thoracic Oncology)